stockrow
Friday 6 November 2026
Export CLB’s income statement to Excel — free account
Core Laboratories Inc.
CLB Energy Oil & Gas Equipment & Services
Core Laboratories Inc.’s revenue for fiscal 2025 (year ended December 2025) was $526.5 million, up 0.51% from fiscal 2024.
- Revenue
- −1.82%
- EPS
- −60.0%
- Free cash flow
- −76.3%
- Total debt
- −66.9%
Quarter to September 2026, against a year earlier
8.84
0.09
−1.01%
Follow CLB
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
25.03 | 27.06 | 22.39 | 28.50 |
P/S ratio |
1.41 | 1.47 | 1.03 | 0.86 | |
P/FCF ratio |
29.38 | 35.83 | 36.64 | 42.99 | |
P/Operating CF |
93.66 | 195.10 | 68.67 | 89.54 | |
P/B ratio |
2.73 | 2.81 | 1.92 | 1.57 | |
Price to Tangible BV |
4.67 | 4.76 | 3.23 | 6.58 | |
EV/Sales |
1.72 | 1.79 | 1.35 | 1.04 | |
EV/EBITDA |
12.75 | 13.70 | 11.21 | 9.95 | |
EV/Operating CF |
24.49 | 27.38 | 24.89 | 21.72 | |
EV/FCF |
35.80 | 43.55 | 47.99 | 51.83 | |
Quick Ratio |
1.35 | 1.32 | 1.37 | 1.33 | |
Current Ratio |
2.02 | 2.05 | 2.12 | 2.19 | |
Net Debt/EBITDA |
4.49 | 16.22 | 7.02 | 1.04 | |
Debt/Assets |
18.88% | 19.47% | 19.40% | 6.37% | |
Debt/Equity |
0.41 | 0.42 | 0.41 | 0.13 | |
Asset Turnover |
0.90 | 0.89 | 0.87 | 0.87 | |
Operating CF/Net income |
1.61 | (5.03) | 1.31 | 0.91 | |
Capex/Depreciation |
(0.85) | (0.90) | (1.09) | (0.98) | |
Interest Coverage |
6.07 | 0.65 | 3.22 | 4.33 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
7.69% | 12.08% | 8.79% | 8.53% | |
Intangible Assets out of Total Assets |
0.19 | 0.19 | 0.19 | 0.36 | |
Share Based Compensation of Revenue |
0.81% | 4.13% | 0.72% | 0.97% | |
Graham Net Nets |
(0.13) | (0.13) | (0.17) | (0.19) | |
Graham Number |
9.19 | 9.13 | 8.42 | 6.89 | |
Earnings Yield |
4.00% | 3.70% | 4.47% | 3.51% | |
Free Cash Flow Yield |
3.40% | 2.79% | 2.73% | 2.33% | |
Revenue per Share |
2.98 | 2.64 | 2.71 | 2.88 | |
Operating CF per Share |
0.17 | 0.09 | 0.17 | 0.11 | |
Capex per Share |
(0.07) | (0.07) | (0.09) | (0.08) | |
Free Cash Flow per Share |
0.10 | 0.01 | 0.08 | 0.03 | |
Cash per Share |
0.49 | 0.50 | 0.49 | 0.47 | |
Shareholders Equity per Share |
5.86 | 5.97 | 6.06 | 6.19 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.86 | 5.97 | 6.06 | 6.19 | |
Free Cash Flow |
4.81 | 0.57 | 3.63 | 1.33 | |
Working Capital |
108.65 | 109.64 | 113.31 | 122.32 | |
Capital Expenditures |
(3.13) | (3.39) | (4.18) | (3.63) | |
Net Current Asset Value |
(97.14) | (98.21) | (93.65) | (84.37) | |
EV/EBIT |
16.06 | 17.43 | 14.69 | 13.78 | |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.03 | |
Price to Operating Income |
13.18 | 14.34 | 11.22 | 11.43 | |
| Other line items | |||||
Average Receivables |
121.44 | 123.09 | 122.02 | 120.27 | |
Average Payables |
35.91 | 39.24 | 40.93 | 38.48 | |
Average Inventory |
56.95 | 58.41 | 58.87 | 59.47 | |
Average Assets |
584.57 | 589.62 | 594.44 | 592.44 | |
Average Common Equity |
262.26 | 267.25 | 273.04 | 280.74 |
Columns are period end dates · fundamentals updated 6 Nov 2026